Diagnostics

4 stories · following the connections

Business

Revvity Raises 2026 Pro Forma EPS Range to $5.40-$5.45

By Helena WardNov 3, 2026, 2:18 PM UTC

Business

Roche Posts 8% Third-Quarter Sales Growth in Swiss Francs

By Helena WardOct 22, 2026, 1:21 PM UTC

Business

Abbott Sales Rise 14.5% in Third Quarter as Net Earnings Fall 44.1%

By Helena WardOct 21, 2026, 9:08 PM UTC

Business

Labcorp Agrees to Buy BioReference Assets for $722 Million

By Helena WardOct 15, 2026, 2:05 PM UTC